OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $2.63 Million in Integer Holdings Corporation $ITGR

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Integer Holdings Corporation (NYSE:ITGR) during the second quarter, Holdings Channel reports. The institutional investor bought 21,375 shares of the medical equipment provider’s stock, valued at approximately $2,628,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Nuveen LLC acquired a new position in Integer in the first quarter valued at $17,634,000. Millennium Management LLC raised its stake in Integer by 2,408.8% during the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock valued at $14,531,000 after acquiring an additional 118,224 shares during the last quarter. Banco Santander S.A. purchased a new position in shares of Integer in the 2nd quarter valued at approximately $12,778,000. Emerald Advisers LLC increased its holdings in shares of Integer by 1,542.0% in the second quarter. Emerald Advisers LLC now owns 103,824 shares of the medical equipment provider’s stock valued at $12,767,000 after purchasing an additional 97,501 shares during the period. Finally, Franklin Resources Inc. raised its stake in shares of Integer by 11.5% during the second quarter. Franklin Resources Inc. now owns 907,232 shares of the medical equipment provider’s stock worth $111,562,000 after purchasing an additional 93,294 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Performance

Integer stock opened at $71.94 on Thursday. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $146.36. The company has a market capitalization of $2.52 billion, a price-to-earnings ratio of 30.10, a PEG ratio of 0.66 and a beta of 0.82. The stock has a fifty day moving average of $79.93 and a two-hundred day moving average of $100.78. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, beating analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.The company’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.43 EPS. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Integer announced that its Board of Directors has initiated a share repurchase program on Tuesday, November 4th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to purchase up to 8.3% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ITGR shares. KeyCorp cut their price objective on shares of Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. Wells Fargo & Company reiterated an “equal weight” rating and set a $80.00 target price (down previously from $132.00) on shares of Integer in a research report on Friday, October 24th. Argus cut Integer from a “buy” rating to a “hold” rating in a report on Friday, October 24th. Bank of America lowered Integer from a “buy” rating to a “neutral” rating and set a $87.00 price objective on the stock. in a report on Friday, October 24th. Finally, Raymond James Financial restated an “outperform” rating and set a $95.00 target price (down from $143.00) on shares of Integer in a research report on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $96.50.

Insider Activity

In other news, EVP Diron Smith acquired 1,116 shares of Integer stock in a transaction that occurred on Friday, November 7th. The shares were acquired at an average price of $67.19 per share, with a total value of $74,984.04. Following the completion of the purchase, the executive vice president owned 7,698 shares of the company’s stock, valued at approximately $517,228.62. This represents a 16.96% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Cheryl C. Capps purchased 1,600 shares of the business’s stock in a transaction on Thursday, November 6th. The stock was acquired at an average price of $66.70 per share, with a total value of $106,720.00. Following the completion of the acquisition, the director directly owned 11,702 shares in the company, valued at $780,523.40. The trade was a 15.84% increase in their position. The SEC filing for this purchase provides additional information. In the last three months, insiders acquired 5,843 shares of company stock worth $384,771. Corporate insiders own 2.16% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.